ScivSPRL BOYKA GRANTCHARSKA-PEDIATRE SPRL
ScivSPRL BOYKA GRANTCHARSKA-PEDIATRE reported total assets of 294,499 € at the end of the 2025 financial year (annual accounts filed with the NBB on 15 Jul 2026).
The score of ScivSPRL BOYKA GRANTCHARSKA-PEDIATRE shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +13 % Total assets -8 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
ScivSPRL BOYKA GRANTCHARSKA-PEDIATRE's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 31,329 € | ||||
| Equity | 274,064 € | ||||
| Cash | 97,586 € | ||||
| EBITDA | 52,218 € | ||||
| Total assets | 294,499 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 15 Jul 2026
- Year ended 31 Dec 2024filed on 25 Sep 2025
- Year ended 31 Dec 2023filed on 30 Sep 2024
- Year ended 31 Dec 2022filed on 25 Jul 2023
- Year ended 31 Dec 2021filed on 25 Aug 2022
ScivSPRL BOYKA GRANTCHARSKA-PEDIATRE's financial analysis
- Solvency93.1%sector median: 67.6%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of ScivSPRL BOYKA GRANTCHARSKA-PEDIATRE
1 active director(s) in the register.
ScivSPRL BOYKA GRANTCHARSKA-PEDIATRE's shareholders and holdings →ScivSPRL BOYKA GRANTCHARSKA-PEDIATRE's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0833.130.921
- VAT number
- No VAT activity declared to the CBE
- Peppol
- Not found on Peppol as of 10 Nov 2026 · Check
- Legal form
- SPRL
- Incorporated
- 29 Dec 2010
- Registered office
- 1000 Brussels
- Latest accounts
- 2025 · filed on 15 Jul 2026
- Activity
- Medical specialists activities (NACE 86220)
ScivSPRL BOYKA GRANTCHARSKA-PEDIATRE (SPRL) has been based in Brussels since 2010, active in: medical specialists activities. For 2025, it reports a net profit of 31,329 € and equity of 274,064 €; its revenue is not published. Its solvency stands at 93.1%, above the median of its sector (67.6%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to ScivSPRL BOYKA GRANTCHARSKA-PEDIATRE
Companies in the same business, of comparable size and area, outside its group.
Frequently asked questions about ScivSPRL BOYKA GRANTCHARSKA-PEDIATRE
What is the revenue of ScivSPRL BOYKA GRANTCHARSKA-PEDIATRE?
ScivSPRL BOYKA GRANTCHARSKA-PEDIATRE files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of ScivSPRL BOYKA GRANTCHARSKA-PEDIATRE?
According to the Crossroads Bank for Enterprises, no VAT-liable activity is declared for ScivSPRL BOYKA GRANTCHARSKA-PEDIATRE. If it is VAT-registered, its VAT number is its company number prefixed with BE: BE0833130921. Its company number (CBE) is 0833.130.921.
Where is the registered office of ScivSPRL BOYKA GRANTCHARSKA-PEDIATRE?
According to the CBE register, the registered office of ScivSPRL BOYKA GRANTCHARSKA-PEDIATRE is in 1000 Brussels.
What is the equity of ScivSPRL BOYKA GRANTCHARSKA-PEDIATRE?
At the close of the 2025 financial year, the equity of ScivSPRL BOYKA GRANTCHARSKA-PEDIATRE amounts to 274,064 €, a solvency of 93.1% of total assets.
Who manages ScivSPRL BOYKA GRANTCHARSKA-PEDIATRE?
The register lists 1 active mandates at ScivSPRL BOYKA GRANTCHARSKA-PEDIATRE. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of ScivSPRL BOYKA GRANTCHARSKA-PEDIATRE
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →